Essex Investment Management »

Haemonetics Corporation shares owned by Essex Investment Management

Quarter-by-quarter ownership of Haemonetics Corporation (HAE) shares owned by Essex Investment Management from 13F filings

Historical chart of Essex Investment Management investment in Haemonetics Corporation

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics Corporation held by Essex Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics Corporation by Essex Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $68k 793 85.35
2023-12-31 $95k 1.1k 85.51
2023-09-30 $1.0M 11k 89.58
2023-06-30 $851k 10k 85.14

More positions owned by Essex Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Hci (HCI)
Nextera Energy (NEE)
salesforce (CRM)
American Superconductor (AMSC)
Primoris Services (PRIM)
D R S Technologies (DRS)
Tenet Healthcare Corporation (THC)
Digi International (DGII)
Amazon (AMZN)
Aspen Aerogels (ASPN)
BP Adr (BP)
Kratos Defense & Security Solutions (KTOS)
Xylem (XYL)

View all positions for Essex Investment Management

Top funds holding Haemonetics Corporation

BlackRock
Vanguard Group
Neuberger Berman Group
Wellington Management Company
Franklin Resources
Royce & Associates
T. Rowe Price Investment Management
Geode Capital Management
Dimensional Fund Advisors
Btim
Westfield Capital Management Company
Fisher Investments
Northern Trust
T. Rowe Price Associates
Charles Schwab Investment Management

View all funds holding Haemonetics Corporation